NewsNZ Ethics Committee Changes
BELTAS Interview
New Zealand Research Agreement
Streamlining Clinical Trials
NZACRes Conference
PGDipClinRes Seminar
ANZTPA Joint Scheme
Clinical Trial Report
Clinical Trials Day
NZ Clinical Trial Guidelines
Extraordinary General Meeting
Annual General Meeting
Training Survey
Medical device clinical trials: the changing scene
This article was originally published in the January-February 2011 issue of Regulatory Affairs Medtech, and appeared on www.regulatoryaffairsmedtech.com on 2 December 2010.
New NZ Good Clinical Research Practice Guideline
Clinical trials of medical devices: the changing scene
This article was published in the December 2010 issue of Clinica Medtech Intelligence (www.clinica.co.uk) Read the article >>
Australian, NZ CROs form Trialliance partnership
Getting Data Faster: A New Australasian Paradigm
BELTAS Clinical Research Achieves 2010 Deloitte Fast 50
RMIANZ Changes Name
BELTAS Attending
BELTAS Submission
Down-under Wonders?
BELTAS Submission
BELTAS Presents
BELTAS Presents
BELTAS in the News
Press Release
BELTAS, a contract research organisation (CRO), manages and monitors clinical studies in hospitals and clinics throughout New Zealand, Australia and Europe. The company also provides internationally accredited training and qualifications in Good Clinical Practice (GCP) for organisations considering or undertaking clinical trials. more >>
Location, Location, Location
|
"VCs poured $7.2 billion -- 28 percent of all venture capital invested last year -- into the fields of biotechnology and medical devices." - Inc.com |
The New Zealand Association of Clinical Research held a special NZACRes meeting today to discuss the Draft SOPs and Application Form for the new Health & Disability Ethics Committees (HDECs) processes with Rohan Murphy, Manager, Ethics Committees, Ministry of Health. These new more streamlined procedures will come into effect on 1 July 2012. For more details see 
BELTAS Managing Director Gerard Dunne was interviewed on Radio New Zealand’s Morning Report this morning, re running clinical trials in New Zealand. The interview included company and industry growth in clinical trials, and the advantages for international biotechnology and medical device firms in conducting their studies in New Zealand. For more details see 
The Government has today released its response to the Health Select Committee's Inquiry into improving New Zealand’s environment to support innovation through clinical trials. "The Government is committed to improving New Zealand's clinical trials environment, and has accepted many of the Health Committee's recommendations on how that should be achieved. For more details see 
BELTAS ran the inaugural GCP seminar for the Victoria University of Wellington Postgraduate Diploma in Clinical Research today. This was delivered to the first intake of largely experienced practitioners, ranging across a number of topics and workshop exercises, and was well received. The seminar will be run annually as part of the Diploma. For more details see 
The New Zealand and Australian governments announced today that they are reviving the ANZTPA scheme, shelved in 2007, for the joint regulation of therapeutic goods. From the ANZTPA site, “The creation of a joint regulatory scheme across both countries will safeguard public health and safety, while encouraging economic integration and benefitting industry in both countries.” More details via 
The ‘Inquiry into improving New Zealand's environment to support innovation through clinical trials’ launched by the NZ Parliament Health Select Committee in February 2010, made its final report public today. The government has 3 months to respond, following which recommendations agreed to will be progressed. Download the report from the Health Select Committee Inquiry page 
In 1747 on 20 May, James Lind conducted the first clinical trial on board his ship patrolling off the Bay of Biscay, looking for a treatment for scurvy. NZACRes celebrated the day last night with food & drink at Iguacu Restaurant, and a presentation from Dr Reuben Broom on his experiences as a Principal Investigator and New Zealand’s position in the global clinical research market. See also 
Over December/January BELTAS ran its training survey. In the vast majority of cases (over 80%) respondents’ organisations paid for their training. Over half did not have a fixed number of training days per year and did training as needs arose. Comments included "The BELTAS GCP course I attended earlier this year was excellent, as it made me really think about what GCP really meant."
Traditionally, most medical device clinical trials have been run "close to home". However, the definition of the terms "close" and "home" is changing rapidly; the device trial landscape is shifting. 
Improvements in communication and transportation technologies mean that the traditional locations for R&D are being challenged by up-and-coming sites. Traditionally, most medical device clinical trials have been run "close to home". However, the definition of the terms "close" and "home" is changing rapidly; the device trial landscape is... 
Three contract research organisations (CROs) spanning Australia and New Zealand have pooled their resources in an effort to attract more clinical trials to the region. The strategic partnership – called Trialliance – involves Clinical Network Services (CNS) and CPR Pharma Services, with headquarters in Brisbane and Adelaide, Australia respectively, as well as the Auckland, New Zealand-based BELTAS. 
Three internationally recognised Australasian contract research companies aim to expand their global market share by joining forces to attract biotech, pharmaceutical and medical device companies to Australia and New Zealand. 
Clinical Trial Evolution in Australia & New Zealand. Has it been growing like the rest of the Asia/Pacific region? Is it still a good place to do clinical research, and what type of clinical trials best suit the habitat? 
Auckland company BELTAS Clinical Research is a 2009 Deloitte Fast 50 winner after a period of strong growth.
Geography, and local knowledge, can be a huge factor when recruiting patients for clinical trials. Gerard Dunne of New Zealand-based CRO BELTAS raises …
